PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Operating without interrupting warfarin reduces risk of bleeding after cardiac device surgery

Bruise Control trial found that patients who were operated on without interrupting warfarin were 80 percent less likely to develop a significant hematoma after surgery compared to patients who were bridged with heparin

2013-05-09
(Press-News.org) DENVER, May 9, 2013 – A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care. The new findings were released today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, and will be published online today in The New England Journal of Medicine (NEJM).

At least a quarter of patients that require pacemaker or implantable defibrillator surgery are taking warfarin to reduce the risk of a stroke. Current guidelines recommend bridging many of these patients to heparin treatment and stopping anticoagulation therapy in the days leading up to surgery which can put a patient at risk of a stroke. The Bruise Control trial is the largest randomized clinical trial to compare continuing warfarin to temporary cessation with heparin bridging in patients before and after device surgery.

"We hope that Bruise Control will change how we are treating patients around the world," said lead author David Birnie, MD, Director of the Arrhythmia Service at the University of Ottawa Heart Institute, Canada. "Our study conclusively shows that treating patients with a high risk of stroke with continued warfarin instead of heparin bridging will improve patient outcomes, decrease complications and reduce hospitalization."

Bruise Control randomized 681 patients at 17 Canadian and 1 Brazilian center with a less than 5 percent annual risk of thrombo-embolic events. One group received continued warfarin, while the other patients were bridged to therapeutic doses of either intravenous heparin or subcutaneous low-molecular-weight heparin starting three days before the procedure and resuming 24 hours after surgery. Patients were evaluated after surgery and the study found that clinically significant hematomas were 80 percent less frequent in patients that received uninterrupted warfarin. Compared to the heparin arm of the trial, patients receiving warfarin had fewer prolonged hospital stays (1.2 percent vs. 4.8 percent), less re-interruption of anticoagulation (3.3 percent vs. 14.5 percent) and fewer re-operations (0.6 percent vs. 2.4 percent). Patients in the continued warfarin arm also had greater satisfaction with their peri-operative anticoagulation management.

Co-Principal Investigator Vidal Essebag, MD, PhD, Director of Cardiac Electrophysiology, McGill University Health Center, Montreal, stated, "To many, the substantial reduction in pocket hematoma that we observed with continued warfarin may be counterintuitive. One explanation that has been proposed is the concept of an 'anticoagulant stress test.' That is, if patients undergo surgery while fully anticoagulated, any excessive bleeding will be detectable and appropriately managed while the wound is still open. In contrast, when surgery is performed with heparin bridging, such bleeding may remain latent, and appear only when full anticoagulation is resumed postoperatively."

The Bruise Control trial was funded by the Canadian Institutes of Health Research (CIHR).

"This randomized clinical trial eliminates a dilemma faced by physicians throughout the world," said Dr. Jean Rouleau, Scientific Director of the CIHR Institute of Circulatory and Respiratory Health. "The study shows that patients requiring cardiac arrhythmia device surgery can remain on their current blood thinners, thus reducing the chance of stroke and hematoma. CIHR is pleased to support Dr. Birnie and his team. Our hope is that this research evidence will soon be brought to the point of care, so it can benefit patients around the world."

### Session details: "Pacemaker and Defibrillator Surgery Without Interruption of Oral Anticoagulation: Results of the Bridge Or warfarin For Device Surgery Randomized Controlled Trial (Bruise Control)" May 9, 2013, 10:30 a.m. – 12:00 p.m. MDT, Four Seasons Ballroom 3]

Heart Rhythm 2013 is the most comprehensive educational program for heart rhythm professionals, featuring more than 8,000 attendees, 250 educational sessions and more than 130 exhibitors showcasing innovative products and services. The Heart Rhythm Society's Annual Scientific Sessions have become the must-attend event of the year, allowing the exchange of new vital ideas and information among colleagues from every corner of the globe.

About the Heart Rhythm Society The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of more than 5,800 heart rhythm professionals in more than 72 countries around the world. For more information, visit http://www.HRSonline.org, voted 2012's "Best in Class" website for a nonprofit by the Interactive Media Council.

About the University of Ottawa Heart Institute The University of Ottawa Heart Institute (UOHI) is Canada's largest and foremost cardiovascular health centre dedicated to understanding, treating and preventing heart disease. UOHI delivers high-tech care with a personal touch, shapes the way cardiovascular medicine is practiced and revolutionizes cardiac treatment and understanding. It builds knowledge through research and translates discoveries into advanced care. UOHI serves the local, national and international community, and is pioneering a new era in heart health. For more information visit: http://www.ottawaheart.ca.

Media contact: Vincent Lamontagne
Senior Manager, Public Affairs
University of Ottawa Heart Institute
613-761-4427
613-899-6760 (cell)
vlamontagne@ottawaheart.ca END


ELSE PRESS RELEASES FROM THIS DATE:

Scripps Research Institute scientists find key to gene-silencing activity

2013-05-09
LA JOLLA, CA – May 9, 2013 – A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases. "Learning to control natural gene silencing processes will allow an entirely new approach to treating human disease," said Ian J. MacRae, assistant professor in TSRI's Department of Integrative Structural and Computational Biology and principal ...

Studies generate comprehensive list of genes required by innate system to defend sex cells

2013-05-09
Cold Spring Harbor, NY – Two teams of investigators led by Professor Gregory Hannon of Cold Spring Harbor Laboratory (CSHL) today publish studies revealing many previously unknown components of an innate system that defends sex cells – the carriers of inheritance across generations – from the ravages of transposable genetic elements. When activated, these troublesome segments of DNA, also called jumping genes or transposons, can copy and insert themselves at random spots across the chromosomes. In sperm and egg cells the proliferation of transposons can be particularly ...

Scientists show how nerve wiring self-destructs

2013-05-09
Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other parts of the body, allowing movement, sight and sense of touch, among other vital functions. Now, researchers at Washington University School of Medicine in St. Louis have found a way the body can remove injured axons, identifying a potential target for new drugs that could prevent the inappropriate loss of axons and maintain ...

No holes in Swiss online networking theory

2013-05-09
Often, it's not what you know, but who you know when it comes to business and research success and that still applies even in the age of online social networking, according to results to be published in the International Journal of Organisational Design and Engineering. Peter Gloor, Pierre Dorsaz, Hauke Fuehres and Manfred Vogel of the MIT Center for Collective Intelligence, in Cambridge, Massachusetts have compared the success of startup entrepreneurs and innovators with their activity on the social networking sites LinkedIn and Facebook as well as email networks including ...

Toddlers from socially-deprived homes most at risk of scalds, study finds

2013-05-09
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums. The results could help GPs and Health Visitors identify those children most at risk of a scald and prevent injuries ...

Scientists demonstrate pear shaped atomic nuclei

2013-05-09
Scientists at the University of Liverpool have shown that some atomic nuclei can assume the shape of a pear which contributes to our understanding of nuclear structure and the underlying fundamental interactions. Most nuclei that exist naturally are not spherical but have the shape of a rugby ball. While state-of-the-art theories are able to predict this, the same theories have predicted that for some particular combinations of protons and neutrons, nuclei can also assume very asymmetric shapes, like a pear where there is more mass at one end of the nucleus than the ...

Scientists develop device for portable, ultra-precise clocks and quantum sensors

2013-05-09
In a joint project between the Universities of Strathclyde and Glasgow, Imperial College London and the National Physical Laboratory, researchers have developed a portable way to produce ultracold atoms for quantum technology and quantum information processing. Their research has been published in the journal Nature Nanotechnology, where it is featured on the front cover. Many of the most accurate measurement devices, including atomic clocks, work by observing how atoms transfer between individual quantum states. The highest precision is obtained with long observation ...

Study finds brain system for emotional self-control

2013-05-09
Different brain areas are activated when we choose to suppress an emotion, compared to when we are instructed to inhibit an emotion, according a new study from the UCL Institute of Cognitive Neuroscience and Ghent University. In this study, published in Brain Structure and Function, the researchers scanned the brains of healthy participants and found that key brain systems were activated when choosing for oneself to suppress an emotion. They had previously linked this brain area to deciding to inhibit movement. "This result shows that emotional self-control involves ...

Research reveals cancer-suppressing protein 'multitasks'

2013-05-09
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers. The p53 protein's functions are normally stimulated by potentially cancer-causing events, such as DNA damage ...

Study finds link between sexual harassment and 'purging' -- in men

2013-05-09
EAST LANSING, Mich. — Men who experience high levels of sexual harassment are much more likely than women to induce vomiting and take laxatives and diuretics in an attempt to control their weight, according to a surprising finding by Michigan State University researchers. Their study is one of the first to examine the effects of sexual harassment on body image and eating behaviors in both women and men. As expected, women reported more sexual harassment and greater overall weight and shape concerns and disordered eating behavior (such as binge eating) in response to that ...

LAST 30 PRESS RELEASES:

New guidelines for managing blood cancers in pregnancy

New study suggests RNA present on surfaces of leaves may shape microbial communities

U.S. suffers from low social mobility. Is sprawl partly to blame?

Research spotlight: Improving predictions about brain cancer outcomes with the right imaging criteria

New UVA professor’s research may boost next-generation space rockets

Multilingualism improves crucial cognitive functions in autistic children

The carbon in our bodies probably left the galaxy and came back on cosmic ‘conveyer belt’

Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target

NASA’s LEXI will provide X-ray vision of Earth’s magnetosphere

A successful catalyst design for advanced zinc-iodine batteries

AMS Science Preview: Tall hurricanes, snow and wildfire

Study finds 25% of youth experienced homelessness in Denver in 2021, significantly higher than known counts

Integrated spin-wave quantum memory

Brain study challenges long-held views about Parkinson's movement disorders

Mental disorders among offspring prenatally exposed to systemic glucocorticoids

Trends in screening for social risk in physician practices

Exposure to school racial segregation and late-life cognitive outcomes

AI system helps doctors identify patients at risk for suicide

Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

Study reveals oldest-known evolutionary “arms race”

People find medical test results hard to understand, increasing overall worry

Mizzou researchers aim to reduce avoidable hospitalizations for nursing home residents with dementia

National Diabetes Prevention Program saves costs for enrollees

Research team to study critical aspects of Alzheimer’s and dementia healthcare delivery

Major breakthrough for ‘smart cell’ design

From CO2 to acetaldehyde: Towards greener industrial chemistry

Unlocking proteostasis: A new frontier in the fight against neurodegenerative diseases like Alzheimer's

New nanocrystal material a key step toward faster, more energy-efficient computing

One of the world’s largest social programs greatly reduced tuberculosis among the most vulnerable

Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

[Press-News.org] Operating without interrupting warfarin reduces risk of bleeding after cardiac device surgery
Bruise Control trial found that patients who were operated on without interrupting warfarin were 80 percent less likely to develop a significant hematoma after surgery compared to patients who were bridged with heparin